#Pharma #Finance #Equityresearch #100dayschallenge #thevaluationschool To view or add a comment, sign in 12,564 followers
Our leadership team proposed gatekeeping with [an online weight-loss management program.] And theyre like, no, we cant afford this at all, so were cutting off [coverage for GLP-1 agonists for weight loss]
Published literature includes papers in journals such as: Nature, Pain, PNS, Blood, BMJ, Spine, Muscle and Nerve, The Lancet, Circulation and BJSM Around 30 LLLT papers published per month Over 4000 laboratory studies and over 400 randomised controlled trials Over 2,500 clinical studies and published research reports have investigated the use of LLLT/PBMT across a variety of health issues
With increased use of GLP-1RA overall, it is imperative to examine whether initiation of GLP-1RA increases the risk of thyroid hormone over-replacement and ultimately elevated risks of AF/Aflutter and stroke among levothyroxine users with T2D